The effect of antioxidant therapy on the course of predialysis chronic kidney disease in a patient with comorbidity

The effect of antioxidant therapy on the course of predialysis chronic kidney disease in a patient with comorbidity

Chronic kidney disease (CKD) is almost always associated with comorbidities such as diabetes, hyperuricemia/gout, urolithiasis, often with urinary tract infection, hypertension, polycystic kidney disease, and other conditions. Autosomal dominant polycystic kidney disease is an inherited kidney disea...

Full description

Bibliographic Details
Main Author:	L.D. Denova
Format:	Article
Language:	English
Published:	Zaslavsky O.Yu. 2023-09-01
Series:	Počki
Subjects:	chronic kidney disease polycystic kidney disease gout hyperuricemia diabetic nephropathy antioxidant therapy glutathione ubiquinone
Online Access:	https://kidneys.zaslavsky.com.ua/index.php/journal/article/view/420

Similar Items

Evaluation of the index of resistance and excretion of uromodulin in patients with predialysis chronic kidney disease, taking into account the index of comorbidity
by: L.D. Denova, et al.
Published: (2023-06-01)

Quality of life of patients with pre-dialysis chronic kidney disease, its relationship with oxidant stress and uromodulin excretion
by: L.D. Denova, et al.
Published: (2023-03-01)

Hyperuricemia in predialysis chronic kidney disease patients in Southern Nigeria
by: Oluseyi A Adejumo, et al.
Published: (2016-01-01)

A Chronic Untreated Tophaceous Gout with Dilated Cardiomyopathy and Chronic Kidney Disease: A Rare Case Report
by: Soma Srinivas Vejendla, et al.
Published: (2023-07-01)

Hyperuricemia and prognosis in chronic kidney disease
by: D.D. Ivanov, et al.
Published: (2017-08-01)

EFFECTIVENESS OF CANEPHRON® N IN THE COMPLEX MANAGEMENT OF SUBCLINICAL GOUTY NEPHROPATHY
by: S. I. Smiyan, et al.
Published: (2016-05-01)

Hyperuricemia and the problem of chronic kidney disease
by: A V Shcherbak, et al.
Published: (2013-06-01)

Dietary antioxidents and oxidative stress in predialysis chronic kidney disease patients
by: Krishan L Gupta, et al.
Published: (2012-10-01)

The Pattern of Allopurinol Prescription Among Chronic Kidney Disease Patients in a Tertiary Care Centre: A Single-Centre Experience
by: Alobaidi S, et al.
Published: (2021-03-01)

Association of hyperuricemia and serum uric acid lowering therapy with mortality in hemodialysis patients
by: Benjamin Rohn, et al.
Published: (2020-01-01)

Cardiovascular risk factors and the impact on prognosis in patients with chronic kidney disease secondary to autosomal dominant polycystic kidney disease
by: José Luis Gorriz, et al.
Published: (2021-03-01)

Hyperuricemia and Progression of Chronic Kidney Disease: A Review from Physiology and Pathogenesis to the Role of Urate-Lowering Therapy
by: Tao Han Lee, et al.
Published: (2021-09-01)

Renoprotective effects of febuxostat compared with allopurinol in patients with hyperuricemia: A systematic review and meta-analysis
by: Sollip Kim, et al.
Published: (2017-09-01)

Association between hyperuricemia and hypertension in chronic kidney disease
by: QIAN Ying, MA Xiaobo, GAO Chenni, ZHANG Chunli, MA Jun, ZHANG Wen, CHEN Xiaonong
Published: (2023-04-01)

Hyperuricemia — an independent factor for the progression of chronic kidney disease
by: M.D. Tronko, et al.
Published: (2017-04-01)

Asymptomatic hyperuricemia: secret relationships, invisible effects and potential complications
by: I. Yu. Golovach, et al.
Published: (2021-01-01)

The fate of nephrons in congenital and heritable renal disorders
by: Robert L. Chevalier
Published: (2013-10-01)

Traditional Chinese herbs and natural products in hyperuricemia-induced chronic kidney disease
by: Letian Yang, et al.
Published: (2022-08-01)

Serum uric acid and acute kidney injury: A mini review
by: Kai Hahn, et al.
Published: (2017-09-01)

Role of Zinc in Diabetic Kidney Disease
by: Guido Gembillo, et al.
Published: (2022-03-01)

Prevalence, age and gender features of chronic kidney disease in patients with diabetes mellitus
by: Ilkhom T. Murkamilov, et al.
Published: (2023-08-01)

Assessment of serum biochemical derangements and associated risk factors of chronic kidney disease
by: Hafiz Rehman Mehmood, BS Hons., et al.
Published: (2022-06-01)

Ultrasonographic findings in patients with chronic kidney disease with asymptomatic hyperuricemia
by: Nashwa Ismail Hashaad, et al.
Published: (2022-10-01)

Risk factors for pulmonary hypertension at the predialysis stage of chronic kidney disease
by: T E Rudenko, et al.
Published: (2016-06-01)

Oxidative Stress Markers in Chronic Kidney Disease with Emphasis on Diabetic Nephropathy
by: Nina Vodošek Hojs, et al.
Published: (2020-09-01)

Dotinurad restores exacerbated kidney dysfunction in hyperuricemic patients with chronic kidney disease
by: Hoichi Amano, et al.
Published: (2024-03-01)

GOUT OUTCOMES. A REVIEW OF LITERATURE. PART 1. GOUT: EPIDEMIOLOGY, RISK FACTORS, COURSE OF THE DISEASE WITH THE DEVELOPMENT OF CHRONIC TOPHUS FORM
by: Igor Sergeyevich Denisov, et al.
Published: (2013-12-01)

Metabolomics Approaches for the Diagnosis and Understanding of Kidney Diseases
by: Hayley Abbiss, et al.
Published: (2019-02-01)

Renal affection in gout
by: Il'ya Vadimovich Egorov, et al.
Published: (2012-01-01)

GOUT OUTCOMES. LITERATURE REVIEW. PART II. COMORBID DISEASES, RISK OF DEVELOPING CARDIOVASCULAR CATASTROPHES AND DEATH IN GOUT PATIENTS
by: Igor Sergeevich Denisov, et al.
Published: (2014-02-01)

Prevalence of normoalbuminuric chronic kidney disease among individuals with type 2 diabetes mellitus from India
by: sChellamma Jayakumari, et al.
Published: (2022-01-01)

Gender-specific association between uric acid level and chronic kidney disease in the elderly health checkup population in China
by: Yanlang Yang, et al.
Published: (2019-01-01)

Influence of oxidative, carbonyl, and nitrosative stresses on the course of chronic kidney disease (analytical review)
by: L.D. Denova, et al.
Published: (2022-02-01)

Assessment of the efficacy of hemodialysis on uric acid clearance in a sub-Saharan African population at the end stage kidney disease
by: Marie Doualla, et al.
Published: (2020-08-01)

Hyperuricemia and diabetes mellitus when occurred together have higher risks than alone on all-cause mortality and end-stage renal disease in patients with chronic kidney disease
by: Cheng-Hung Li, et al.
Published: (2022-04-01)

Potential Role of Copper in Diabetes and Diabetic Kidney Disease
by: Guido Gembillo, et al.
Published: (2022-12-01)

Diabetes mellitus and chronic kidney disease: achievements, unresolved problems, and prospects for therapy
by: Marina Vladimirovna Shestakova, et al.
Published: (2011-03-01)

Administration of antioxidants in chronic kidney disease
by: Tamadon Mohamad Reza, et al.
Published: (2015-01-01)

Antidiabetic and Other Therapies Used in Subjects with Diabetes and Chronic Kidney Disease in a Hospital-Based Clinic Population in Greece
by: Ilias N. Migdalis, et al.
Published: (2021-05-01)

Physicians' perceptions of asymptomatic hyperuricemia in patients with chronic kidney disease: A questionnaire survey
by: Ran-hui Cha, et al.
Published: (2019-09-01)